Preclinical study of the human recombinant Erythropoietin (GBPD002) compared with Eprex
Kakon Nag, Mohammad Mohiuddin, Md. Maksudur Rahman Khan, Samir Kumar, Enamul Haq Sarker, Rony Roy, Bipul Kumar Biswas, Uttam Barman, Sheik Rejaul Haq, Sitesh Chandra Bachar, Naznin Nahar Sultana
This study compares the safety and toxicity of GBPD002 and Eprex(R), two recombinant human erythropoietins, in rats, finding similar toxicological profiles and no significant differences.
bioRxiv · Jun 5, 2024 · PreprintPharmacology & Toxicology